Abir Alamro
Impact in
-
- Tryptophan and brain disorders
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- Moudhi Almutlaq (7 shared papers)Samina Hyder Haq (8 shared papers)Amani Alghamdi (17 shared papers)Tlili Barhoumi (5 shared papers)Qura Tul Ain (3 shared papers)Sarah Al-Rashed (2 shared papers)Tanveer A. Wani (1 shared paper)Majid Ahmad Ganaie (1 shared paper)
- Journals
- Journal of King Saud University - Science (3 papers)Heliyon (2 papers)Scientific Reports (2 papers)Journal of Biomolecular Structure and Dynamics (1 paper)Biology (1 paper)
- Partner nations
- Saudi ArabiaPakistanUnited States
In The Last Decade
Abir Alamro
30 papers receiving 479 citations
Peers
Comparison fields: 5 of 93
- Biological Psychiatry 27
- Pharmaceutical Science 44
- Aquatic Science 52
- Molecular Medicine 30
- Pharmacology 40
Countries citing papers authored by Abir Alamro
This map shows the geographic impact of Abir Alamro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abir Alamro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abir Alamro more than expected).
Fields of papers citing papers by Abir Alamro
This network shows the impact of papers produced by Abir Alamro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abir Alamro. The network helps show where Abir Alamro may publish in the future.
Co-authors
The 25 scholars most cited alongside Abir Alamro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 105 | |
| 2 | 2021 | 63 | |
| 3 | 2017 | 48 | |
| 4 | 2021 | 41 | |
| 5 | 2020 | 28 | |
| 6 | 2023 | 23 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 18 | |
| 9 | 2021 | 17 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2018 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2019 | 4 | |
| 20 | Frequency of occurrence of cytomegalovirus and Chlamydia pneumoniae in lymphocytes of atherosclerotic patients. | 2001 | 4 |
About Abir Alamro
Abir Alamro is a scholar working on Molecular Biology, Pharmacology, Hematology, Infectious Diseases and Pathology and Forensic Medicine, having authored 35 papers that have together received 485 indexed citations. Recurring topics across this work include Vitamin D Research Studies (3 papers), Estrogen and related hormone effects (2 papers), Seaweed-derived Bioactive Compounds (2 papers), Iron Metabolism and Disorders (2 papers), COVID-19 Clinical Research Studies (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Nanoparticles: synthesis and applications (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Biological Psychiatry (27 citations), Pharmaceutical Science (44 citations), Aquatic Science (52 citations), Molecular Medicine (30 citations) and Pharmacology (40 citations). Abir Alamro has collaborated with scholars based in Saudi Arabia, Pakistan and United States. Frequent co-authors include Moudhi Almutlaq, Samina Hyder Haq, Amani Alghamdi, Tlili Barhoumi, Qura Tul Ain, Sarah Al-Rashed, Tanveer A. Wani, Majid Ahmad Ganaie, Seema Zargar and Sadia Sarwar. Their work appears in journals such as Journal of King Saud University - Science, Heliyon, Scientific Reports, Journal of Biomolecular Structure and Dynamics and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.